Status:
RECRUITING
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Lead Sponsor:
University of Pittsburgh
Conditions:
Cutaneous T-cell Lymphoma
Sezary Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Detailed Description
The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor: ...
Eligibility Criteria
Inclusion
- 18 or older
- able and willing to provide informed consent
- diagnosed with CTCL
- diagnosed with either atopic dermatitis or eczema
Exclusion
- Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2032
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00177268
Start Date
October 1 2004
End Date
January 1 2032
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213